Bigul

Global Health Ltd - 543654 - Outcome Of Board Meeting Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 (Listing Regulations)

This is with reference to the letter Ref. No.- GHL/2022-23/EXCH/022 dated 13th February, 2023, wherein the Board of Directors of the Company has approved the binding Term Sheet for a new hospital at Indore on Operation & Management basis. In this regard, the Board of Directors of the Company at its Board Meeting held today i.e. Monday, 27th March, 2023, has extended the validity of Term Sheet till June 23, 2023 (earlier 60 days from date of execution) to execute necessary agreement subject to completion of due diligence. The Company has appointed a law firm, JSA advocates & solicitors, for the purposes of conducting the said due diligence and the same is underway. There are no changes in the disclosure made pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 on February 13, 2023 except above.
27-03-2023
Bigul

Global Health Ltd - 543654 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Dear Sir/Madam, Pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the representatives of following Investors/Analysts are scheduled to meet the Management of the Company, as per the below schedule attached in the intimation. Please note that, no Unpublished Price Sensitive Information is proposed to be shared thereat. Kindly take the above on record.
25-03-2023
Bigul

Global Health Ltd - 543654 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

Dear Sir/Madam, This is to inform you that the Board of Directors of the Company on 17th March, 2023 vide Resolution passed by circulation has allotted 10,290 Equity Shares of face value of Rs. 2/- each to 1 (One) eligible employee upon exercise of options vested under ESOP 2016 Scheme. Consequent to the aforesaid allotment, the paid-up share capital of the Company has increased from 26,81,84,882 equity shares to 26,81,95,172 equity shares. In terms of Regulation 10(c) of the SEBI SBEB & SE Regulations, the details of shares allotted are given in "Annexure -I". You are requested to kindly take the above on record.
17-03-2023
Bigul

Global Health Ltd - 543654 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Dear Sir/Madam, Pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the representatives of following Investors/Analysts are scheduled to meet the Management of the Company, as per the schedule attached. Please note that, no Unpublished Price Sensitive Information is proposed to be shared, thereat. Kindly take the above on record.
07-03-2023
Bigul

Global Health Ltd - 543654 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Dear Sir/Madam, Pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the representatives of following Investors/Analysts are scheduled to meet the Management of the Company at 'Medanta - The Medicity', Gurugram, Haryana - 122001, as per the schedule attached. Please note that, no Unpublished Price Sensitive Information is proposed to be shared, thereat. Kindly take the above on record.
25-02-2023
Bigul

Global Health Ltd - 543654 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Dear Sir/Madam, Pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that Company's officials are scheduled to meet investors and analysts in Mumbai on 23rd February, 2023. The List of Investors are as under: 1. HDFC Life; 2. WhiteOak; 3. Birla MF; and 4. Enam Asset Management This is for your information and record.
21-02-2023
Bigul

Global Health Ltd - 543654 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Dear Sir/Madam, Pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that Company's officials are scheduled to meet investors and analysts in Mumbai on 22nd February, 2023. The List of Investors are as under: 1. Sundaram MF; 2. PGIM MF; 3. Mirae MF; 4. SBI MF; and 5. Jefferies India This is for your information and record.
21-02-2023
Bigul

Global Health Ltd - 543654 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Dear Sir/Madam, Pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that Company's officials will be attending in person, the Kotak Chasing Growth 2023 Conference, organized by Kotak Securities Limited in Mumbai on 21st February, 2023. This is for your information and record.
20-02-2023
Bigul

Global Health Ltd - 543654 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

Dear Sir/Madam, Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find the below link of transcript of Earnings Conference Call held on Tuesday, February 14, 2023 hosted by JM Financials, for the Quarter III & Nine Months ended December 31, 2022 Results of the Company. https://www.medanta.org/investor_relations/quarterly-financial-results/conference-call-transcript The Transcript is also attached herewith for your reference.
20-02-2023
Bigul

Global Health Ltd - 543654 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Dear Sir/Madam, Pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the representatives of the following Investors are scheduled to visit our Gurugram Facility i.e. 'Medanta - The Medicity' for in-person meetings, on Friday, 17th February, 2023: S. No. Name of the Investor 1. Wellington International Management 2. Taiyo Pacific Please note that, no Unpublished Price Sensitive Information is proposed to be shared, thereat. Kindly take the above on record.
16-02-2023
Next Page
Close

Let's Open Free Demat Account